PetMed Express (PETS) grants director Peter Batushansky 55,555 restricted shares

Rhea-AI Filing Summary

Batushansky Peter reported acquisition or exercise transactions in this Form 4 filing.

PetMed Express Inc. director Peter Batushansky reported a grant of 55,555 shares of common stock as a restricted stock award under the PetMed Express, Inc. 2024 Omnibus Incentive Plan. The award vests in full on August 11, 2027, subject to his continued service on the Board of Directors, bringing his direct holdings to 91,928 shares.

Insider Trade Summary

Net Buyer: 55,555 shares

Net Buy 1 txn

Insider Batushansky Peter

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	55,555	$0.00	$0.00

Holdings After Transaction: Common Stock — 91,928 shares (Direct)

Footnotes (1)

1. F1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors.

Key Figures

Restricted stock award: 55,555 shares Post-transaction holdings: 91,928 shares Grant price per share: $0.00 +1 more

4 metrics

Restricted stock award 55,555 shares Grant of common stock to director Peter Batushansky on 2026-08-11

Post-transaction holdings 91,928 shares Total common shares directly held after the award

Grant price per share $0.00 Reported transaction price per share for the restricted stock award

Vesting date August 11, 2027 All granted restricted shares vest on this date, subject to continued board service

Key Terms

restricted stock award, 2024 Omnibus Incentive Plan, continued service on the Board of Directors

3 terms

restricted stock award financial

"Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

2024 Omnibus Incentive Plan financial

"award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests"

continued service on the Board of Directors financial

"vests as to all granted shares on August 11, 2027, subject to continued service on the Board"

FAQ

What insider transaction did PETS director Peter Batushansky report?

Director Peter Batushansky reported a grant of 55,555 shares of PetMed Express common stock. The award is a restricted stock grant under the 2024 Omnibus Incentive Plan and was reported at a price of $0.00 per share as compensation, not a market purchase.

When do the newly granted PETS shares to Peter Batushansky vest?

The 55,555 restricted shares granted to Peter Batushansky vest on August 11, 2027. Vesting is conditioned on his continued service on the Board of Directors through that date, as specified in the grant footnote.

How many PETS shares does Peter Batushansky hold after this Form 4 transaction?

Following the reported restricted stock grant, Peter Batushansky directly holds 91,928 shares of PetMed Express common stock. This total includes the 55,555-share award that is subject to vesting conditions through August 11, 2027.

What type of equity award did PETS grant to director Peter Batushansky?

PetMed Express granted Peter Batushansky a restricted stock award of 55,555 common shares. The award was issued under the PetMed Express, Inc. 2024 Omnibus Incentive Plan and vests entirely on August 11, 2027, assuming continued board service.

Was the PETS Form 4 transaction a market purchase or sale?

No market trade occurred; the Form 4 reports a grant/award acquisition. The 55,555 shares of common stock were awarded at a $0.00 per-share price as director compensation, rather than being bought or sold in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 04:18 PM Accepted by SEC EDGAR 08/12/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Batushansky Peter

(Last) (First) (Middle)

C/O PETMED EXPRESS, INC.

420 SOUTH CONGRESS AVENUE

(Street)

DELRAY BEACH FLORIDA 33445

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		A		55,555(1)	A	$0	91,928	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors.

Remarks:

	/s/ Peter Batushansky	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)